N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide

C111H128N16O4 — CID 159051784

IUPACN-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide
SMILESNc1ccc(-c2cnc(NC(=O)CCCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)CCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc4ccccc4c3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccccc3)c(CCC3CCCCC3)n2)cc1
InChIInChI=1S/C30H32N4O.C28H34N4O.C27H32N4O.C26H30N4O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h4-5,8-10,12-16,18,20-21H,1-3,6-7,11,17,19,31H2,(H,32,34,35);1,3-4,8-9,15-18,20,22H,2,5-7,10-14,19,29H2,(H,30,32,33);2,5-6,9-10,13-16,19-20H,1,3-4,7-8,11-12,17-18,28H2,(H,29,31,32);2,5-6,9-10,12-15,18-19H,1,3-4,7-8,11,16-17,27H2,(H,28,30,31)
InChIKeyJXIWENLGPRWSHC-UHFFFAOYSA-N
MW1750.35 g/mol
LogP24.00
Rot. Bonds31

About N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide

N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide (PubChem CID 159051784) has the molecular formula C111H128N16O4 and a molecular weight of 1750.35 g/mol. Its IUPAC name is N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide
PubChem CID159051784
Molecular FormulaC111H128N16O4
Molecular Weight1750.35 g/mol
Exact Mass1749.03
IUPAC NameN-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide
SMILESNc1ccc(-c2cnc(NC(=O)CCCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)CCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc4ccccc4c3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccccc3)c(CCC3CCCCC3)n2)cc1
InChIInChI=1S/C30H32N4O.C28H34N4O.C27H32N4O.C26H30N4O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h4-5,8-10,12-16,18,20-21H,1-3,6-7,11,17,19,31H2,(H,32,34,35);1,3-4,8-9,15-18,20,22H,2,5-7,10-14,19,29H2,(H,30,32,33);2,5-6,9-10,13-16,19-20H,1,3-4,7-8,11-12,17-18,28H2,(H,29,31,32);2,5-6,9-10,12-15,18-19H,1,3-4,7-8,11,16-17,27H2,(H,28,30,31)
InChIKeyJXIWENLGPRWSHC-UHFFFAOYSA-N
XLogP24.00
TPSA323.60 Ų
H-Bond Donors8
H-Bond Acceptors16
Rotatable Bonds31
Heavy Atoms131
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001750.35
LogP ≤ 524.00
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclohexyl-N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)acetamide;N-(3,5-diphenylpyrazin-2-yl)benzamide;N-(3,5-diphenylpyrazin-2-yl)-2-naphthalen-2-ylacetamide;N-(3,5-diphenylpyrazin-2-yl)-2-phenylacetamide;N-(3,5-diphenylpyrazin-2-yl)-4-phenylbutanamide;N-(3,5-diphenylpyrazin-2-yl)-3-phenylpropanamide
CID 159829946
N-[3-(cyclopentylmethyl)-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide
CID 136624996
N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-methylbutanamide
CID 89009351
N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-[(E)-2-phenylethenyl]pyrazin-2-yl]-3-phenylpropanamide
CID 160783148
N-[3-(2-cyclohexylethyl)-5-(4-fluorophenyl)pyrazin-2-yl]-2-(4-methylphenyl)acetamide
CID 143000334
2-(4-chlorophenyl)-N-[3-(2-cyclohexylethyl)-5-(4-hydroxyphenyl)pyrazin-2-yl]acetamide
CID 136625233
N-[3-(2-cyclohexylethyl)-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-(4-methylphenyl)acetamide;ethane
CID 143000636
N-[5-(4-aminophenyl)-3-(2-phenylethenyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide
CID 77496997
N-[3-(cyclohexylmethyl)-5-[4-(hydroxymethyl)phenyl]pyrazin-2-yl]-2-phenylacetamide
CID 123882448
N-[3-(2-cyclohexylethyl)-5-[4-(hydroxymethyl)phenyl]pyrazin-2-yl]-3-methylbutanamide
CID 123781945
N-[5-(4-aminophenyl)-3-[(3,5,8-trimethyl-3-bicyclo[7.1.0]dec-8-enyl)methyl]pyrazin-2-yl]-4-phenylbutanamide
CID 143000878
N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide
CID 59510395

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide?
The IUPAC name of N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide (CID 159051784) is N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide.
What is the SMILES notation for N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide?
The canonical SMILES for N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide is Nc1ccc(-c2cnc(NC(=O)CCCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)CCc3ccccc3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccc4ccccc4c3)c(CCC3CCCCC3)n2)cc1.Nc1ccc(-c2cnc(NC(=O)Cc3ccccc3)c(CCC3CCCCC3)n2)cc1.
What is the InChIKey of N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide?
The InChIKey is JXIWENLGPRWSHC-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H32N4O.C28H34N4O.C27H32N4O.C26H30N4O/c31-26-15-13-24(14-16-26)28-20-32-30(27(33-28)17-11-21-6-2-1-3-7-21)34-29(35)19-22-10-12-23-8-4-5-9-25(23)18-22;29-24-17-15-23(16-18-24)26-20-30-28(25(31-26)19-14-22-10-5-2-6-11-22)32-27(33)13-7-12-21-8-3-1-4-9-21;28-23-15-13-22(14-16-23)25-19-29-27(24(30-25)17-11-20-7-3-1-4-8-20)31-26(32)18-12-21-9-5-2-6-10-21;27-22-14-12-21(13-15-22)24-18-28-26(30-25(31)17-20-9-5-2-6-10-20)23(29-24)16-11-19-7-3-1-4-8-19/h4-5,8-10,12-16,18,20-21H,1-3,6-7,11,17,19,31H2,(H,32,34,35);1,3-4,8-9,15-18,20,22H,2,5-7,10-14,19,29H2,(H,30,32,33);2,5-6,9-10,13-16,19-20H,1,3-4,7-8,11-12,17-18,28H2,(H,29,31,32);2,5-6,9-10,12-15,18-19H,1,3-4,7-8,11,16-17,27H2,(H,28,30,31).
What are the key properties of N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide?
N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide has a molecular weight of 1750.35 g/mol, XLogP of 24.00, 31 rotatable bonds, 8 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-2-phenylacetamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-aminophenyl)-3-(2-cyclohexylethyl)pyrazin-2-yl]-3-phenylpropanamide is sourced from PubChem (CID 159051784), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).